CPRX
Catalyst Pharmaceuticals, Inc. · Healthcare · Biotechnology
Señales de momentum (gestores comparables):
amplitud de titulares +30.0% ·
flujo de acciones -2.4% ·
nuevas posiciones netas +20.0%
— fórmula
Fragmentación de la titularidad — más titulares, participación agregada menor
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q3 2024
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 109 | -4 | 77.02M | $2.42B | +12 | −16 |
| Q1 2026 | 116 | +4 | 78.68M | $1.95B | +8 | −4 |
| Q4 2025 | 111 | 0 | 78.17M | $1.82B | — | — |
| Q3 2025 | 19 | 0 | 48.11M | $947.78M | — | −1 |
| Q2 2025 | 17 | +1 | 43.29M | $939.35M | +1 | — |
| Q1 2025 | 13 | -1 | 14.99M | $363.56M | — | −1 |
| Q4 2024 | 14 | 0 | 15.06M | $314.25M | +1 | −1 |
| Q3 2024 | 13 | +3 | 9.07M | $180.23M | +4 | −1 |
| Q2 2024 | 10 | — | 9.29M | $143.84M | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (pasivo) | 2.66M | -1.3% | $52.98M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 2 | Geode Capital Management ✦ (pasivo) | 2.66M | -1.3% | $52.98M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 3 | Renaissance Technologies ✦ | 2.53M | +16.1% | $50.22M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 4 | T. Rowe Price ✦ | 1.23M | +0.1% | $24.54M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | T. Rowe Price ✦ | 1.23M | +0.1% | $24.54M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | Marshall Wace ✦ | 860.93K | -29.4% | $17.12M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 7 | Millennium Management ✦ | 559.77K | +331.2% | $11.13M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | AQR Capital Management ✦ | 459.35K | -5.9% | $9.13M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | AQR Capital Management ✦ | 459.35K | -5.9% | $9.13M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 459.35K | -5.9% | $9.13M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 11 | Arrowstreet Capital ✦ | 301.65K | Nuevo | $6.00M | 0.0% | New | 1 | SEC ↗ |
| 12 | Two Sigma Investments ✦ | 159.31K | Nuevo | $3.17M | 0.0% | New | 1 | SEC ↗ |
| 13 | Norges Bank ✦ (pasivo) | 91.77K | Nuevo | $1.82M | 0.0% | New | 1 | SEC ↗ |
| 14 | Fisher Asset Management ✦ | 86.80K | -17.8% | $1.73M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 15 | Wellington Management ✦ | 59.58K | Nuevo | $1.18M | 0.0% | New | 1 | SEC ↗ |
| 16 | Wellington Management ✦ | 59.58K | Nuevo | $1.18M | 0.0% | New | 1 | SEC ↗ |
| 17 | Wellington Management ✦ | 59.58K | Nuevo | $1.18M | 0.0% | New | 1 | SEC ↗ |
| 18 | Wellington Management ✦ | 59.58K | Nuevo | $1.18M | 0.0% | New | 1 | SEC ↗ |
| 19 | Gotham Asset Management ✦ | 36.14K | +7.2% | $718,483 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 20 | Citadel Advisors ✦ | 25.24K | -95.7% | $501,731 | 0.0% | ▼ Trim | 2 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Arrowstreet Capital | $6.00M | 0.0% |
| Two Sigma Investments | $3.17M | 0.0% |
| Norges Bank | $1.82M | 0.0% |
| Wellington Management | $1.18M | 0.0% |
| Wellington Management | $1.18M | 0.0% |
| Wellington Management | $1.18M | 0.0% |
| Wellington Management | $1.18M | 0.0% |
Posición cerrada
| Point72 Asset Management | $9.58M | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 378 tenedores, 103.75M acciones, $2.50B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.